Also available in Persian — نسخه فارسی EN فا
❓ Unknown

Surge in AMH Fertility Tests Among Australian Women Raises Concerns Over Predictive Accuracy

6d ago September 10, 2026 1 min read 📰 Medical Xpress
📋 Key Takeaway

A study from Flinders University reveals that the use of anti-Müllerian hormone (AMH) fertility tests among Australian women has surged over the past decade, yet the tests do not predict natural pregnancy outcomes. This trend reflects broader concerns about fertility assessments, which may resonate with Iranian women facing similar reproductive health issues. Understanding these developments is crucial for addressing women's health policies in Iran.

🔍 Quick Context Guide
💡 Bottom Line: The surge in AMH testing among Australian women raises critical questions about the accuracy of fertility assessments, with implications for women's health policies globally.

👥 Key Players

Flinders University MENTIONED
Research institution
"Their research influences medical practices and policies related to women's health, which can impact similar contexts in Iran."
Australian General Practitioners (GPs) MENTIONED
Healthcare providers
"They play a crucial role in prescribing fertility tests and shaping public perceptions about fertility health."

📰 What Happened

A significant increase in the use of AMH fertility tests among Australian women has been observed, but new research indicates these tests do not accurately predict natural pregnancy outcomes. This raises concerns about the reliability of fertility assessments.

  • AMH test requests by GPs increased more than 13-fold from 2011 to 2021.
  • The tests have been shown to not predict future natural pregnancies.

💡 Why It Matters

🇮🇷 For Iran: The findings may resonate with Iranian women who face similar fertility concerns, highlighting the need for accurate health information and policies.
🌍 Regional: This issue reflects broader regional challenges regarding women's health and reproductive rights.
🌐 International: The findings could prompt international discussions on the reliability of fertility tests and women's health policies.

📚 Background

AMH tests are used to evaluate a woman's ovarian reserve, but their predictive value for natural pregnancy is questionable. This is particularly relevant in discussions about women's reproductive health.

Women's reproductive health Fertility treatments
📡 Source: NEUTRAL
📊 Confidence: 70%
The study is published in a peer-reviewed journal, indicating a level of credibility, but interpretations may vary.

Increasing numbers of Australian women are using a blood test to assess their fertility, but new research suggests it may not provide the answers many are looking for. A study led by Flinders University and published in the Australian and New Zealand Journal of Obstetrics and Gynaecology found requests by GPs for anti-Müllerian hormone (AMH) tests increased more than 13-fold between 2011 and 2021, despite growing evidence that the test cannot predict whether a woman will become pregnant naturally—not now or in the future.

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 100%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →